Amount Raised
$4.74 Million
Round Type
Post-IPO Equity
Description
On November 3, 2026, BioVie Inc. entered into a securities purchase agreement with an institutional investor to raise approximately $4.74 million through a registered direct offering. The offering included shares of Class A common stock and pre-funded warrants. The gross proceeds will be utilized for working capital and corporate purposes.
Quick answer
BioVie raised $4.74 Million in a Post-IPO Equity round, dated November 6, 2026.
- How much did BioVie raise?
- BioVie raised $4.74 Million in a Post-IPO Equity round on November 6, 2026.
- What does BioVie do?
- BioVie Inc. is a biopharmaceutical company focused on the development of therapies for chronic liver diseases and cognitive disorders.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as BioVie that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
- Ensho Therapeutics raised $7.3M on October 2, 2026.
Who to call at BioVie, and when
A new round usually means BioVie is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioVie raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioVie, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioVie. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioVie raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BioVie raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.